Related Experiment Videos
Flow cytometry. Clinical and research applications in hematologic malignancies
1Section of Transfusion Medicine and Laboratory Immunology, University of Texas M. D. Anderson Cancer Center, Houston.
Hematology/Oncology Clinics of North America
|August 1, 1994
Summary
Flow cytometry is crucial for diagnosing leukemias and lymphomas, aiding in monitoring treatment and detecting minimal residual disease. Recent advancements enhance its clinical and research applications in hematologic malignancies.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Flow cytometric immunophenotyping is integral to diagnosing hematologic malignancies.
- It complements traditional morphology by defining cell lineage and differentiation.
- Its utility extends to post-therapy monitoring and minimal residual disease detection.
Purpose of the Study:
- To review recent advancements in flow cytometry for hematologic malignancies.
- To highlight the clinical and research applications of this technology.
Main Methods:
- Review of recent literature on flow cytometry in hematologic malignancies.
- Analysis of clinical and research applications.
Main Results:
- Flow cytometry provides essential diagnostic information for leukemias and lymphomas.
- It is valuable for disease monitoring and detecting minimal residual disease.
- Recent developments have expanded its utility in hematologic oncology.
Conclusions:
- Flow cytometry is a key tool in the diagnosis and management of hematologic malignancies.
- Continued advancements are improving its application in clinical and research settings.
- This technique is vital for understanding and treating blood cancers.